0001140361-21-007543.txt : 20210305 0001140361-21-007543.hdr.sgml : 20210305 20210305191220 ACCESSION NUMBER: 0001140361-21-007543 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210303 FILED AS OF DATE: 20210305 DATE AS OF CHANGE: 20210305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADVENT INTERNATIONAL CORP/MA CENTRAL INDEX KEY: 0001034196 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720189 BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 6179510555 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII Limited Partnership CENTRAL INDEX KEY: 0001556190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720188 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A Limited Partnership CENTRAL INDEX KEY: 0001559259 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720186 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A Cayman Limited Partnership CENTRAL INDEX KEY: 0001559260 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720182 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII Cayman Limited Partnership CENTRAL INDEX KEY: 0001561808 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720184 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII 2014 Limited Partnership CENTRAL INDEX KEY: 0001616578 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720187 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617 951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-B Cayman Limited Partnership CENTRAL INDEX KEY: 0001563878 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720181 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-951-9400 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 75 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII 2014 Cayman Limited Partnership CENTRAL INDEX KEY: 0001616563 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720183 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A 2014 Cayman Limited Partnership CENTRAL INDEX KEY: 0001616564 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720180 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Advent Partners GPE VII-A 2014 Limited Partnership CENTRAL INDEX KEY: 0001616577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36730 FILM NUMBER: 21720185 BUSINESS ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-951-9493 MAIL ADDRESS: STREET 1: C/O ADVENT INTERNATIONAL CORPORATION STREET 2: 800 BOYLSTON STREET, SUITE 3300 CITY: BOSTON STATE: MA ZIP: 02199 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syneos Health, Inc. CENTRAL INDEX KEY: 0001610950 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 273403111 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-876-9300 MAIL ADDRESS: STREET 1: 1030 SYNC STREET CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: INC Research Holdings, Inc. DATE OF NAME CHANGE: 20140616 4 1 form4.xml FORM 4 X0306 4 2021-03-03 0001610950 Syneos Health, Inc. SYNH 0001034196 ADVENT INTERNATIONAL CORP/MA PRUDENTIAL TOWER, 800 BOYLSTON STREET SUITE 3300 BOSTON MA 02199-8069 true 0001556190 Advent Partners GPE VII Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616578 Advent Partners GPE VII 2014 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001559259 Advent Partners GPE VII-A Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616577 Advent Partners GPE VII-A 2014 Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001561808 Advent Partners GPE VII Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616563 Advent Partners GPE VII 2014 Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001559260 Advent Partners GPE VII-A Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001563878 Advent Partners GPE VII-B Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true 0001616564 Advent Partners GPE VII-A 2014 Cayman Limited Partnership C/O ADVENT INTERNATIONAL CORPORATION 800 BOYLSTON STREET, SUITE 3300 BOSTON MA 02199-8069 true Class A Common Stock 2021-03-03 4 S 0 4331222 74.175 D 11087573 I See Notes Class A Common Stock 2021-03-03 4 S 0 322824 74.175 D 10764749 I See Notes See Exhibit 99.1 for text of footnote (1). See Exhibit 99.1 for text of footnote (2). See Exhibit 99.1 for text of footnote (3). See Exhibit 99.1 for text of footnote (4). See Exhibit 99.1 for text of footnote (5). Exhibit 99.1 (Footnotes to Form 4) and Exhibit 99.2 (Signatures and Joint Filer Information) are incorporated herein by reference. This Form 4 is the third of six Form 4s being filed relating to the same event. This Form 4 has been split into six filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10. Each part will be filed by Designated Filer, Advent International Corporation. See Exhibit 99.2 2021-03-05 EX-99.1 2 ex99_1.htm EXHIBIT 99.1
Exhibit 99.1
Name and Address of Reporting Person:
Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
Date of Earliest Transaction Required to be Reported:
March 3, 2021
(Month/Day/Year)
  

Footnotes to Form 4
(1) Represents shares of Class A Common Stock (“Common Stock”) of Syneos Health, Inc. (the “Issuer”) sold in connection with a secondary offering of the Issuer’s Common Stock (the “Offering”) by the following entities: 74,013 shares sold by Advent International GPE VIII-C Limited Partnership (“GPE VIII-C”) and 4,257,209 shares sold by Double Eagle Investor Holdings, L.P. (“Double Eagle Investor Holdings”), of which: 883 shares were indirectly sold by Advent Partners GPE VII Limited Partnership, 2,261 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 2,087 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 6,198 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 15,055 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 5,090 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 3,980 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 20,638 shares were indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 3,591 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership (collectively, the “Advent Partners GPE VII Funds”); 188,486 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 418,188 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 32,688 shares were indirectly sold by Advent International GPE VII-H Limited Partnership (collectively, the “GPE VII GP Funds”); 203,641 shares were indirectly sold by Advent International GPE VII Limited Partnership, 580,566 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 184,498 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 121,924 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 53,837 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 53,837 shares were indirectly sold by Advent International GPE VII-G Limited Partnership (collectively, the “GPE VII GP S.a.r.l. Funds”); 137,196 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 454,449 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 161,261 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 120,234 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 187,750 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 63,296 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 18,759 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 166,185 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 154,534 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 151,861 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership (collectively, the “GPE VIII GP S.a.r.l. Funds”); 321,810 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 70,495 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 119,563 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 65,800 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 64,756 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership (collectively, the “GPE VIII GP Funds”); 31,617 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 4,209 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 54,092 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 5,306 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 6,588 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership (collectively, the “Advent Partners GPE VIII Funds”).

(2) Represents shares of Common Stock sold to the Issuer (the “Private Sale”) by the following entities: 5,516 shares sold by GPE VIII-C and 317,308 shares sold by Double Eagle Investor Holdings, of which: 66 were indirectly sold by Advent Partners GPE VII Limited Partnership,169 shares were indirectly sold by Advent Partners GPE VII 2014 Limited Partnership, 156 shares were indirectly sold by Advent Partners GPE VII-A Limited Partnership, 462 shares were indirectly sold by Advent Partners GPE VII-A 2014 Limited Partnership, 1,122 shares were indirectly sold by Advent Partners GPE VII (Cayman) Limited Partnership, 379 shares were indirectly sold by Advent Partners GPE VII 2014 Cayman Limited Partnership, 297 shares were indirectly sold by Advent Partners GPE VII-A (Cayman) Limited Partnership, 1,538 shares indirectly sold by Advent Partners GPE VII-B (Cayman) Limited Partnership, 268 shares were indirectly sold by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 14,049 shares were indirectly sold by Advent International GPE VII-A Limited Partnership, 31,169 shares were indirectly sold by Advent International GPE VII-E Limited Partnership, 2,436 shares were indirectly sold by Advent International GPE VII-H Limited Partnership; 15,178 shares were indirectly sold by Advent International GPE VII Limited Partnership, 43,271 shares were indirectly sold by Advent International GPE VII-B Limited Partnership, 13,751 shares were indirectly sold by Advent International GPE VII-C Limited Partnership, 9,087 shares were indirectly sold by Advent International GPE VII-D Limited Partnership, 4,013 shares were indirectly sold by Advent International GPE VII-F Limited Partnership, 4,013 shares were indirectly sold by Advent International GPE VII-G Limited Partnership; 10,226 shares were indirectly sold by Advent International GPE VIII Limited Partnership, 33,872 shares were indirectly sold by Advent International GPE VIII-B Limited Partnership, 12,019 shares were indirectly sold by Advent International GPE VIII-B-1 Limited Partnership, 8,962 shares were indirectly sold by Advent International GPE VIII-B-2 Limited Partnership, 13,994 shares were indirectly sold by Advent International GPE VIII-B-3 Limited Partnership, 4,718 shares were indirectly sold by Advent International GPE VIII-D Limited Partnership, 1,398 shares were indirectly sold by Advent International GPE VIII-F Limited Partnership, 12,386 shares were indirectly sold by Advent International GPE VIII-H Limited Partnership, 11,518 shares were indirectly sold by Advent International GPE VIII-I Limited Partnership, 11,319 shares were indirectly sold by Advent International GPE VIII-J Limited Partnership; 23,986 shares were indirectly sold by Advent International GPE VIII-A Limited Partnership, 5,254 shares were indirectly sold by Advent International GPE VIII-E Limited Partnership, 8,912 shares were indirectly sold by Advent International GPE VIII-G Limited Partnership, 4,904 shares were indirectly sold by Advent International GPE VIII-K Limited Partnership, 4,827 shares were indirectly sold by Advent International GPE VIII-L Limited Partnership; 2,357 shares were indirectly sold by Advent Partners GPE VIII Cayman Limited Partnership, 314 shares were indirectly sold by Advent Partners GPE VIII-A Cayman Limited Partnership, 4,032 shares were indirectly sold by Advent Partners GPE VIII-B Cayman Limited Partnership, 395 shares were indirectly sold by Advent Partners GPE VIII Limited Partnership, and 491 shares were indirectly sold by Advent Partners GPE VIII-A Limited Partnership.
 
(3) Following the Offering and the Private Sale, Advent manages funds that collectively own 10,764,749 shares, which are represented as follows: 183,949 shares held directly by GPE VIII-C and 10,580,800 shares held directly by Double Eagle Investor Holdings, of which: 2,196 shares are indirectly owned by Advent Partners GPE VII Limited Partnership, 5,620 shares are indirectly owned by Advent Partners GPE VII 2014 Limited Partnership, 5,189 shares are indirectly owned by Advent Partners GPE VII-A Limited Partnership, 15,404 shares are indirectly owned by Advent Partners GPE VII-A 2014 Limited Partnership, 37,418 shares are indirectly owned by Advent Partners GPE VII (Cayman) Limited Partnership, 12,649 shares are indirectly owned by Advent Partners GPE VII 2014 Cayman Limited Partnership, 9,892 shares are indirectly owned by Advent Partners GPE VII-A (Cayman) Limited Partnership, 51,294 shares are indirectly owned by Advent Partners GPE VII-B (Cayman) Limited Partnership, 8,925 shares are indirectly owned by Advent Partners GPE VII-A 2014 (Cayman) Limited Partnership; 468,460 shares are indirectly owned by Advent International GPE VII-A Limited Partnership, 1,039,358 shares are indirectly owned by Advent International GPE VII-E Limited Partnership, 81,241 shares are indirectly owned by Advent International GPE VII-H Limited Partnership; 506,127 shares are indirectly owned by Advent International GPE VII Limited Partnership, 1,442,928 shares are indirectly owned by Advent International GPE VII-B Limited Partnership, 458,546 shares are indirectly owned by Advent International GPE VII-C Limited Partnership, 303,027 shares are indirectly owned by Advent International GPE VII-D Limited Partnership, 133,805 shares are indirectly owned by Advent International GPE VII-F Limited Partnership, 133,805 shares are indirectly owned by Advent International GPE VII-G Limited Partnership; 340,984 shares are indirectly owned by Advent International GPE VIII Limited Partnership, 1,129,480 shares are indirectly owned by Advent International GPE VIII-B Limited Partnership, 400,794 shares are indirectly owned by Advent International GPE VIII-B-1 Limited Partnership, 298,830 shares are indirectly owned by Advent International GPE VIII-B-2 Limited Partnership, 466,630 shares are indirectly owned by Advent International GPE VIII-B-3 Limited Partnership, 157,316 shares are indirectly owned by Advent International GPE VIII-D Limited Partnership, 46,622 shares are indirectly owned by Advent International GPE VIII-F Limited Partnership, 413,033 shares are indirectly owned by Advent International GPE VIII-H Limited Partnership, 384,076 shares are indirectly owned by Advent International GPE VIII-I Limited Partnership, 377,434 shares are indirectly owned by Advent International GPE VIII-J Limited Partnership; 799,821 shares are indirectly owned by Advent International GPE VIII-A Limited Partnership, 175,207 shares are indirectly owned by Advent International GPE VIII-E Limited Partnership, 297,160 shares are indirectly owned by Advent International GPE VIII-G Limited Partnership, 163,539 shares are indirectly owned by Advent International GPE VIII-K Limited Partnership,160,943 shares are indirectly owned by Advent International GPE VIII-L Limited Partnership; 78,583 shares are indirectly owned by Advent Partners GPE VIII Cayman Limited Partnership, 10,463 shares are indirectly owned by Advent Partners GPE VIII-A Cayman Limited Partnership, 134,441 shares are indirectly owned by Advent Partners GPE VIII-B Cayman Limited Partnership, 13,187 shares are indirectly owned by Advent Partners GPE VIII Limited Partnership, and 16,373 shares are indirectly owned by Advent Partners GPE VIII-A Limited Partnership.

(4) Advent is the Sole Member of Double Eagle GP, LLC, which in turn is the General Partner of Double Eagle Investor Holdings. Advent is the Manager of Advent International GPE VII, LLC (“GPE VII LLC”) and Advent International GPE VIII, LLC (“GPE VIII LLC”).

GPE VII, LLC is the General Partner of GPE VII GP S.a.r.l. (“GPE VII GP S.a.r.l.”), GPE VII GP Limited Partnership (“GPE VII GP”), and the Advent Partners GPE VII Funds. GPE VII GP is the General Partner of the GPE VII GP Funds. GPE VII GP S.a.r.l. is the General Partner of the GPE VII GP S.a.r.l. Funds.

GPE VIII LLC is the General Partner of GPE VIII GP Limited Partnership (“GPE VIII GP”), GPE VIII GP S.a.r.l. (“GPE VIII GP S.a.r.l.”), and AP GPE VIII GP Limited Partnership (“AP GPE VIII GP”). GPE VIII GP S.a.r.l. is the General Partner of the GPE VIII GP S.a.r.l. Funds and of GPE VIII-C. GPE VIII GP is the General Partner of the GPE VIII GP Funds. AP GPE VIII GP is the General Partner of the Advent Partners GPE VIII Funds.

(5) Each of the entities named above are referred to herein as “Reporting Persons.” Each Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its respective pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or any other purpose.


 EX-99.2 3 ex99_2.htm EXHIBIT 99.2
Exhibit 99.2
Joint Filer Information

Name of Joint Filer:
Double Eagle Investor Holdings, L.P.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE INVESTOR HOLDINGS, L.P.
By:
Double Eagle GP, LLC, its General Partner
By:
Advent International Corporation, its Sole Member

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 1 of 48
Joint Filer Information

Name of Joint Filer:
Double Eagle GP, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069

10% Owner
Relationship of Joint Filer to Issuer:
  
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

DOUBLE EAGLE GP, LLC
By:
Advent International Corporation, its Sole Member

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 2 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-C Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069

10% Owner
Relationship of Joint Filer to Issuer:
  
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
    
     
ADVENT INTERNATIONAL GPE VIII-C LIMITED PARTNERSHIP
    
By:
 GPE VIII GP S.à r.l., its General Partner    
By:
 Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
 Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 3 of 48
Joint Filer Information

Name of Joint Filer:
GPE VIII GP S.à r.l.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

GPE VIII GP S.à r.l.
    
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 4 of 48
 Joint Filer Information

Name of Joint Filer:
GPE VIII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
  
   
GPE VIII GP LIMITED PARTNERSHIP
  
By:
Advent International GPE VIII, LLC, its General Partner
 
By:
Advent International Corporation, its Manager
 

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date

 
Page 5 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT INTERNATIONAL GPE VIII, LLC
  
By:
 Advent International Corporation, its Manager  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 6 of 48
Joint Filer Information

Name of Joint Filer:
GPE VII GP S.à r.l.
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
    
     
GPE VII GP S.à r.l.
    
By:
 Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 7 of 48
Joint Filer Information

Name of Joint Filer:
GPE VII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
  
   
GPE VII GP LIMITED PARTNERSHIP
  
By:
Advent International GPE VII, LLC, its General Partner
 
By:
Advent International Corporation, its Manager
 

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 8 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII, LLC
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
  

 
ADVENT INTERNATIONAL GPE VII, LLC
  
By:
Advent International Corporation, its Manager  

By:
  
/s/ Michael Ristaino
  
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 9 of 48
Joint Filer Information

Name of Joint Filer:
AP GPE VIII GP Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
AP GPE VIII GP LIMITED PARTNERSHIP
  
By:
Advent International GPE VIII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 10 of 48
Joint Filer Information

Name of Joint Filer
Advent Partners GPE VIII Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VIII CAYMAN LIMITED PARTNERSHIP
By:
AP GPE VIII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VIII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date

 
Page 11 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-B Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VIII-B CAYMAN LIMITED PARTNERSHIP
By:
AP GPE VIII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VIII, LLC, its General Partner
  
By: Advent International Corporation, its Manager  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 12 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VIII LIMITED PARTNERSHIP
By:
AP GPE VIII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VIII, LLC, its General Partner
  
By: Advent International Corporation, its Manager  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 13 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VIII-A LIMITED PARTNERSHIP
By:
AP GPE VIII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VIII, LLC, its General Partner
  
By: Advent International Corporation, its Manager  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 14 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VIII-A Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VIII-A CAYMAN LIMITED PARTNERSHIP
By:
AP GPE VIII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VIII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 15 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT INTERNATIONAL GPE VII-A LIMITED PARTNERSHIP
By:
GPE VII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 16 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-E Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT INTERNATIONAL GPE VII-E LIMITED PARTNERSHIP
By:
GPE VII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 17 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-H Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT INTERNATIONAL GPE VII-H LIMITED PARTNERSHIP
By:
GPE VII GP Limited Partnership, its General Partner
  
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 18 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 19 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII 2014 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII 2014 LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 20 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII-A LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 21 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A 2014 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII-A 2014 LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 22 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII CAYMAN LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 23 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII 2014 Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII 2014 CAYMAN LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 24 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite
 
Boston, MA 02199-8069 3300
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII-A CAYMAN LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 25 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-B Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII-B CAYMAN LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 26 of 48
Joint Filer Information

Name of Joint Filer:
Advent Partners GPE VII-A 2014 Cayman Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
   
ADVENT PARTNERS GPE VII-A 2014 CAYMAN LIMITED PARTNERSHIP
By:
Advent International GPE VII, LLC, its General Partner
  
By:
Advent International Corporation, its Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 27 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
  
ADVENT INTERNATIONAL GPE VIII LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner  
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 28 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
  
ADVENT INTERNATIONAL GPE VIII-B LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 29 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-1 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
ADVENT INTERNATIONAL GPE VIII-B-1 LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner    
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 30 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-2 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]
   
Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
ADVENT INTERNATIONAL GPE VIII-B-2 LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
    
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 31 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-B-3 Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
ADVENT INTERNATIONAL GPE VIII-B-3 LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 32 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-D Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
 
ADVENT INTERNATIONAL GPE VIII-D LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 33 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-F Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-F LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
    
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 34 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-H Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-H LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner    
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 35 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-I Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:
     
ADVENT INTERNATIONAL GPE VIII-I LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 36 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-J Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-J LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VIII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 37 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-A Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-A LIMITED PARTNERSHIP
By:
GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 38 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-E Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-E LIMITED PARTNERSHIP
By:
GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 39 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-G Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-G LIMITED PARTNERSHIP
By:
GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 40 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-K Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner

Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-K LIMITED PARTNERSHIP
By:
GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 41 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VIII-L Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VIII-L LIMITED PARTNERSHIP
By:
GPE VIII GP Limited Partnership, its General Partner
By: Advent International GPE VIII, LLC, its General Partner
By: Advent International Corporation, its Manager

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 

 
Page 42 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 43 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-B Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-B LIMITED PARTNERSHIP
By:
GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  
 
By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 44 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-C Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-C LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By: Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By: Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 45 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-D Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-D LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 46 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-F Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-F LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date
 
 
Page 47 of 48
Joint Filer Information

Name of Joint Filer:
Advent International GPE VII-G Limited Partnership
Address of Joint Filer:
c/o Advent International Corporation
 
Prudential Tower, 800 Boylston Street, Suite 3300
 
Boston, MA 02199-8069
Relationship of Joint Filer to Issuer:
10% Owner
Issuer Name and Ticker or Trading Symbol:
Syneos Health, Inc. [SYNH]

Date of Earliest Transaction Required
  
to be Reported (Month/Day/Year):
March 3, 2021
Designated Filer:
Advent International Corporation

Signature:

ADVENT INTERNATIONAL GPE VII-G LIMITED PARTNERSHIP
By: GPE VII GP S.à r.l., its general partner
By:
Advent International GPE VII, LLC, its Manager
/s/ Jarlyth Gibson
  
By:
Advent International Corporation, its Manager
Jarlyth Gibson, Manager
  

By:
  
/s/ Michael Ristaino
    
Name: Michael Ristaino
  
Title: Vice President of Finance - Fund Administration
  

March 5, 2021
Date


 
Page 48 of 48